MerckAnnouncesFirstPatientDosedinPhase3StudyforInvestigationalAntibody-DrugConjugateinColorectalCancer
===2026/5/22 9:21:42===
re Medicine. 2025.
3
Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669-685. doi:10.1001/jama.2021.0106.
4
Xie Y-H, Chen Y-X, Fang J-Y. Comprehensive review of targeted therapy for colorectal cancer. Signal Transduction and Targeted Therapy. 2020/03/20 2020;5(1):22. doi:10.1038/s41392-020-0116-z.
5
Martínez-Lago N, Chucla TC, De Castro BA, et al. Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting. Scientific Reports. 2022/08/26 2022;12(1):14612. doi:10.1038/s41598-022-18871-9.
=*=*=*=*=*=
当前为第9/10页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页